Ask the Experts: Safety and Efficacy of Microbiome-Targeted Therapies for the Prevention of C. difficile Infection

Clostridioides difficile infection (CDI) is a threat to public health and recurrence is common. Treatment options for recurrent CDI continue to evolve to include non-antibiotic therapies, including fecal microbiota transplantation (FMT). With increasing evidence of the relationship between dysbiosis and gastrointestinal and metabolic diseases, FMT has been developed to focus on microbiome repair for the treatment of recurrent CDI. This educational activity will address the safety and efficacy of traditional FMT and other live biotherapeutic products.


Wednesday, Mar. 8
12:00 - 1:00 p.m. ET

Speakers

Travis J. Carlson Travis J. Carlson PharmD, BCIDP
 Activity Chair
Assistant Professor
High Point University
High Point, North Carolina

Kelly R. RevelesKelly R. Reveles PharmD, PhD, BCPS
Associate Professor,
College of Pharmacy
The University of Texas at Austin San Antonio, Texas



Target Audience

The target audience for this educational activity is pharmacists who practice in hospitals, health systems, and ambulatory clinics as well as transitions of care pharmacists who care for or are interested in the care of patients with recurrent CDI.

Learning Objectives

  • Differentiate probiotics from traditional fecal microbiota transplantation (FMT) and other live biotherapeutic products (LBPs).
  • Summarize the existing safety and efficacy data for probiotics, traditional FMT, and other LBPs.
  • Choose an appropriate microbiome-targeted therapy for the prevention of C.  difficile infection.

Agenda

  • 12:00 p.m. Welcome and Introductions
    Travis J. Carlson, PharmD, BCIDP and Kelly R. Reveles, PharmD, PhD, BCPS
  • 12:05 p.m. Ask the Experts: Safety and Efficacy of Microbiome-Targeted Therapies for the Prevention of C. difficile Infection 
    Travis J. Carlson, PharmD, BCIDP and Kelly R. Reveles, PharmD, PhD, BCPS
  • 12:50 p.m. Questions and Answers
    Travis J. Carlson, PharmD, BCIDP and Kelly R. Reveles, PharmD, PhD, BCPS

Accredited for CPE

ACPE #: 0204-0000-23-401-L01-P
CE Credit: 1.0 contact hours (0.10 CEUs)
Activity Type: Application-based
Activity Fee: No charge

To Claim CE for the webinar, enter the CE code announced during the activity and complete the evaluation.

 

 

ACPE logo black and white The American Society of Health-System Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education with Commendation.
ASHP Advantage logo Provided by ASHP. Supported by an educational grant from Ferring Pharmaceuticals Inc.
For questions and assistance to participate, contact us.